ࡱ> FCDE - \pMustafa Dungarwalla [-Mustafa DungarwallaBa==xx;I 8X@"1Arial1Arial1Arial1Arial1 Arial1.8Eras Medium ITC1.8Eras Medium ITC18Arial1 Arial1$Arial1Arial""#,##0;\-""#,##0""#,##0;[Red]\-""#,##0""#,##0.00;\-""#,##0.00#""#,##0.00;[Red]\-""#,##0.005*0_-""* #,##0_-;\-""* #,##0_-;_-""* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-=,8_-""* #,##0.00_-;\-""* #,##0.00_-;_-""* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)72_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).)_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)61_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                       ( (P  (X Q x@ @ 8 |@ @ 8 *0"@@ *0"@ *0 " @ (@ @ *@ @ *@ @ 1(@ @ (@ @ (0 *@ @ Q  `THIN Publication%]PLEASE READ - Sorting Options,8fNf8@     /<R)9(ۮzkÜF9(ۮzkÜJFIF,, 4ExifMM*bj(1r2i-'-'Adobe Photoshop CS2 Macintosh2008:03:07 12:53:18&(. HHJFIFHH Adobe_CMAdobed            $" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?p?_u?4U¿ddtʭuX@hhmWwZ/XQXL{916)F2ҽ!p?R2m녘>G۬1f˾PlGor %>wS?ׇ}T6Νq.:ze#MG^un勫`.Um<4Q<+Sp~O]CY+a9 snNYvʳ:O:Μ̚KcXWnW)OY꘧~'Ve5=FfR+&ʿvjwG -+Y}g!YO~Tp:׵9Jz ohk~C@ MG^u@W_NfuN.eP=ϹjwVSg謷Rǫ՝ZKPгSufM\öksmkX6WbJvƎESrVRKZKṀ{/N\ud]"r)ό]J?SMG^uEg]=o*kn.A.cnoޕCz#l}jf٘T?VE_ VRI$б0?ٔc\,k]Ϻk=1y#,Mz͒14*sp2}3[hkc[FMg%e/:YJm'OVhII>tJxY];ы:e+x̚徣>mN?K^^tE#)))ק/XWzX)dᴷHswn?{n_3$/>e>_~gzw?IimezĒ~2ݟMFI&/~#B_oA|ĒJ~#o I)wu%FI$7_1$[_oA|ĒJ~#o R~O=z^_$wo}W}Gk_wGzS}_~og_6P.0Photoshop 3.08BIM8BIM%F &Vڰw8BIM com.apple.print.PageFormat.PMHorizontalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMHorizontalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMOrientation com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMOrientation 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.subTicket.paper_info_ticket com.apple.print.PageFormat.PMAdjustedPageRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPageRect 0.0 0.0 783 559 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:53:04Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMAdjustedPaperRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPaperRect -18 -18 824 577 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:53:04Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMPaperName iso-a4 com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print .PaperInfo.PMUnadjustedPageRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPageRect 0.0 0.0 783 559 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMUnadjustedPaperRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPaperRect -18 -18 824 577 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2008-03-07T12:52:32Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.ppd.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.ppd.PMPaperName A4 com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PaperInfoTicket com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PageFormatTicket 8BIMxHH/8Ag{HH(dh 8BIM,,8BIM&?8BIM 8BIM8BIM 8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM]CSD_epic_logo_spot_knullboundsObjcRct1Top longLeftlongBtomlongRghtlongslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlongRghtlongurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM $C JFIFHH Adobe_CMAdobed            $" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?p?_u?4U¿ddtʭuX@hhmWwZ/XQXL{916)F2ҽ!p?R2m녘>G۬1f˾PlGor %>wS?ׇ}T6Νq.:ze#MG^un勫`.Um<4Q<+Sp~O]CY+a9 snNYvʳ:O:Μ̚KcXWnW)OY꘧~'Ve5=FfR+&ʿvjwG -+Y}g!YO~Tp:׵9Jz ohk~C@ MG^u@W_NfuN.eP=ϹjwVSg謷Rǫ՝ZKPгSufM\öksmkX6WbJvƎESrVRKZKṀ{/N\ud]"r)ό]J?SMG^uEg]=o*kn.A.cnoޕCz#l}jf٘T?VE_ VRI$б0?ٔc\,k]Ϻk=1y#,Mz͒14*sp2}3[hkc[FMg%e/:YJm'OVhII>tJxY];ы:e+x̚徣>mN?K^^tE#)))ק/XWzX)dᴷHswn?{n_3$/>e>_~gzw?IimezĒ~2ݟMFI&/~#B_oA|ĒJ~#o I)wu%FI$7_1$[_oA|ĒJ~#o R~O=z^_$wo}W}Gk_wGzS}_~og_6P8BIM!UAdobe PhotoshopAdobe Photoshop CS28BIM:http://ns.adobe.com/xap/1.0/ image/jpeg Adobe Photoshop CS2 Macintosh 2008-03-07T12:52:40Z 2008-03-07T12:53:18Z 2008-03-07T12:53:18Z uuid:9D219567EDD711DC971AFE4F5BD1A339 uuid:9D21956CEDD711DC971AFE4F5BD1A339 uuid:6AFA0830D64911DC9BB6B3B8CC0990AF uuid:6AFA082ED64911DC9BB6B3B8CC0990AF 3 sRGB IEC61966-2.1 < 1 3000000/10000 3000000/10000 2 256,257,258,259,262,274,277,284,530,531,282,283,296,301,318,319,529,532,306,270,271,272,305,315,33432;8A52C41E550253EDCE1A0BCF2B7068ED 1181 263 1 36864,40960,40961,37121,37122,40962,40963,37510,40964,36867,36868,33434,33437,34850,34852,34855,34856,37377,37378,37379,37380,37381,37382,37383,37384,37385,37386,37396,41483,41484,41486,41487,41488,41492,41493,41495,41728,41729,41730,41985,41986,41987,41988,41989,41990,41991,41992,41993,41994,41995,41996,42016,0,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,20,22,23,24,25,26,27,28,30;F4B306581D1C5AC8481D2119550FE4EB < XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖ< ޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobed@     u!"1A2# QBa$3Rqb%C&4r 5'S6DTsEF7Gc(UVWdte)8fu*9:HIJXYZghijvwxyzm!1"AQ2aqB#Rb3 $Cr4%ScD&5T6Ed' sFtUeuV7)(GWf8vgwHXhx9IYiy*:JZjz ?QQo#s_ֺ>׼uGo{ߺח^k{^&]R߫ |A38s?a>A48s?b>}{hp:I>A48s?aꞵϯM\?uOXoO^?ι~{zM\?uOX{OC׿&?>S^ |uTߪz߂>A48s?a>}{hp:I zA38s?b?^??ιz>A38s?aꞵϯM\?uOX.ϡGT_Kef!؅#0{Wj<퉩&*lGWּ=_Vnlq(槤Wٽ/-\V%bgSI!jUM$ -Z-x馅 ػcogl}COnn=f+5SjF5ҷߺ^׽u~{ߺ^׽u~{ߺ^t5~O=zf@fse7t(pKnR%VٷYM6@[~`hz#_+S_iiIj%~=02es0AZ%7_~:!?Pu? <yuH喒:ͩ VՔ_ǒYUt炟>SGw\?OX})zuTߪzׂ>A48s?bꞽϯM\?_>_[S 'Wx)zuT߫׼={hp:Iu=^?޹~~]oOC׿&?Tּ߫ 'W 'Wx)zuT߫׼ 'Wx)zuT߫׼ 'Wx)^UWGXjwݸ`8"8uws0TQ_UWȞY [ޕ؝g_{ Gr J|f?p6W*ג[zma=lVw ^n `76gsT8*NRXdta>]?^׺u{{^׺u{<)|y=nJlv'|lQ6^m|&C&ە5=fR,jU$0T=Ppf68YeyzΙ]) 1V&@k~]9Ϭ_G?OS~˯x)G?OS/~[S׿&?>S׼ 'T=^?ι{O[S׿&?yּ߫$ 'X^^ϯMߝs?a>}{hp:I |uT߫׼={gp:_^^ϯL\?uOXo׿&?^^ϯL\?OX}{ 'Wּ 'W)Gθ<6c=CY¯ͨݹ񧸨C~9;+%*qY=(%_uu շzn~|~/'N$uç>Rm{[풔)6@ꎨaa?o?#nUdڽ_ox"I㣒ĄXtV^#k{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺uкQyc}}Xu{׾}v^ֽ:uu~]^'^Sz<϶[GZ?^G{׼ʝ^'\ɿ]a^׽u~u{{^׺CeŻ?_7}~,?mYM7_t|]{ߺ^׽u~{ߺ^׽u~{ߺ^׽u J:H%:zjjjxY*'(`$,*$~h%?F˶3?m!ݽUIIQU7 ٺfLj)d+=Z}?^m֟ǖv$GGbYV/,;K,YfbI$uG^׽u~{ߺ^^׺޺^׽u~{ߺ^׽u~{ߺ^׽u~{}{3[?s7j|Pn)WPf2qTv_ǝӒ~n赵;}, zl>5rW]>OQ/?ǽ'srUּ^ڹSM}C/O 89ڵ8㪮"Cxg58Č_:ߒ_'hin~,WqU* %iS"vvۥ-hq(`YγҥPt{[׺u{{^׺u׽u~{ߺ]{^{^{^׺u}{{^}ul|X{ls7-˗W)KQ"G93uHr*Xd]fu鷌7ˎл+_ԛ4b5;SqPl. vmʷU;2Rh^ZyaM Fcߺ^׽u~{ߺ^0c=#W>rco_|rõQ3ؽM24~)F?:]5I$V<zg B#]G1q(.IDBL@pz_{S?v yR;0+_qb'on>(*edM An׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽uѺ*Q-0xk_^>ֺ޺]{׿ߺ:/OgqyO>o#b?FR/#k~}NYXN['_=k,ΰ˯{^:^׽^׺u{qnW_ow;K[CVg,>?SMW3::^׽u~{ߺ^׽u~{ߺ^׽u~i kN-.7yݤ|XJ׃%7o -];YNƣ-e< S$}çMGQ:*@UQPpzS~׺uR?^_?ۏ~z^?n=uC^?n=uC׺ǿuo{\Q{^ڗߺ]\Q]׺Gq{\Q{^_?ۏzw{{^׺?ˏNn T_#믐 &G;V A8i3*l,մǧMȁO L1TSƓA<.42xT,E"0ee$n=欄e׽u~{ߺ^׽u@ϻEz!AUqJNt.гc˜$wԿiS vZH(c>5_1s93y͹Ymɹ&[!{=3ܵT\g)[$ՙ,FwifI}ץxߺ^W@^ߺ^^׺]_8{\Q{^뫏?ۏ{wq׮?n=uKa׮׺Q{]n=u֡Gq}{?ۏz{RQߺ]^׺rc텽w|c7ujkjb6v&#vT3arqipNjJ}5*jG_Q{/^׽u~{ߺ^k8uϟVv[_~޾FKtw]^ďxZ+{j_׵CW׺Po]{]ߺ^?o{j׺+Gq]{j_?=uCPn?׺׺]_?ۏzzPo{j?ۏ~v׺u{{^?wU_y ucq :~:f`ĩL7'vfΥvtr4H"k=o`Ŏݻxωύŏ)HBKt$* o},u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽uҺ*QQo_0|ߺ^}{u׽u~ޝ{{^}}u~^'^Sz,Ƕ[GZ?^G{׼ʝ__s+&ҶOzחYu]{ߺ^׽u~㎽׽u~{ߺW ݟ{zvOXuotu{{^׺u{{^׺u{{^Qf|M?$@Ozq7C6ZBr2-˛J,uTT[ǯv.]5؝wW\lCD18JC "5mʍ3r5.ܰizL+,qȊyꪠriEwNۿ[Qml]>/Ԕ;bY9,uUfEFc5[!Fc$zkS><+?o*6R{z֦#O^xVSMG ?/?I{S<+?o)R{z#O^xVSMG ?/_I]{S<+Oo)R{z#O^xVSMG ?/_Iuڛ={Z|]Oޫ׵7z3l'Wjo?gix wE>O~^i}Ԟ^׿??g=jo?gix wE>O{^ir`|9l3@U2y~,{U}Tcj ԙQ3l}? >@UE^>PMջlMC?`z%guA! ST%@{_mbA<4UFYhqm=@dR3({L]3m'׭jo?gix wE>Oz^i}Ԟ^׿??k=jo?gix wE>O{^iԞ^׿?7g={S<+O)R{׵7z3l'Wjo?ggx {E>O{^i}Ԟ^׿?7g={S<+?o)R{z#O^xVTm^i}Ԟ׵7z +#1u|Fn\G]-ӟ J]fV}u}}w]nlk/k_}ۤL(:~{ߺ^׽u~VX|`Oj}udҿtw]^>}!"SWz펷uud'|3r!5ڜejIO-F69eI УZ|]OmMG ?.?IUڛ={Z|^O׵7z3l'uMG ?/_Iuڛ={Z|]Oޫ׵7z3m'uMG ?/_Iuڛ={Y|^O߫׵7z3m'uMG /_Iuڛ={Z|^O߫׵7z3m'Wjo?gix{E>Ozڛ={Z^Oߺ#OXNhO۱>RXXdžRA׵7+Lj۝55,rs=#; ݍS6i6>5 XZzua#> 79ԸܾkO{z)YoJ̅8 {+!]PM1KոjuH;3+Pi=}:}{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺZ:úCn|-#uf_Gud#DIr\]6'~lY@yYQaç9#%}ץ{ߺ_AoH2?]:|&zeQm:esroo!Y!ut^׽u~{ߺT˜ln{}m,L0nb)֮vc E.G S`P{K~׺!|gXr9S gT -V*H(s1RObi|$T|\lN[Gja67^<;ll(pU:P)bX.Ť;;3􏥯u{{^׺u{{^׺u{{^׺u{{^׺uf]>"9ڝy؝cji)2u^_l6}t`e(o$P|>:KFC?\{KߺW t"wWϦ?>>^{{^׺u{{^׺u{{^׺u{{^׺u{k?J˷~E&oͽFLu4=o^re8zx% u.JEUP9`<_5?O{^cJmO汍sJ[c3\myPz\mTm7陇hz[Iu{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺ԺQQs=b׿ƽyu׺Ͽuk׿׏~]{ߺW7Wދ3O/:#ie/??fTjՄ띟}[7ּˬ2{߇^N׽u~{ߩ^׽uz.-xkaKhe~Ji"ۭ=󣮘~{ߺ^׽u~{ߺ^׽u~{ߺZM?_r|7S{|Mu{^g + ,Y<-~B8#ZlgTwzY5X̮@% ߺk{^׺u{{^׺u{{^׺u{{^׺u{{^\SÍz&,%~;6*jܮcٝCMV`pX-M(g*"4q_>gJ, VV \{JF$UUA,T[ߺ_LoLwÝkz>~){iVZ,#]()3|\@)q+p-IN:ߺo{^׺u{mUw G}^3Z43=Wߘ>y|=}{޺[<~K|ђuEޱLc5`ӜXȅ-Ơ{zO?~~鎽{{^׺u{{^׺u{{^׺u{{^׺u{^?U?7?{s<č;|鰛rSRCl_Tc%\{N|V VR u #+uE,<$~rOu?{ظm]>@-J\oJ #drYe;jUHd`-:G! ^ϿuN{{^׺u[۬>|v>:K2_X{KߺW t"yWϦ?>>^{{^׺u{{^׺u{{^׺u{{^׺u{r_ߟ?]ul>ouw]^1OT{:jo}}={ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~պ*QQLZ׺Sߺzum~{'>׺u{dEq=<XQ@ t_SkVv}oVWZ{.˯{^^׽u~{ߺW ݟ{zvX}ugtu.{{^׺u{{^׺u{{^IY{O_o~<:zδoz}?"?Ÿ_:ݼIf.׺u{{^׺u{{^׺u{{^׺u{{^׺YYYC+VR,U>ߺZ|/9ٻ ~=}NWqSty/Jܧ6|#YWQ!y 62سK~ǧF_뿆k{7~O_)S7tOSq9Z)c8lf#=YG#oTfgO>P4dE*+p#68}w{{^׺u{q_O=Y~%G_#!G:[~׺Lo wʿ{}57~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~VVbíĿo_#auw]^1OT{驾~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽uֺ*jj?"WL>Zoߺ^_~}{{}׽u׺uOoYگ)g-#aFR/#k~NYXN['^=k,u~{ߺ^׽u~u{{^?>?\[{a]Nՙ<E[{G]1׺u{{^׺u{{^׺uǻn>&:ѻzS׽u@ۿu_v%ߺk{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺Jﭙd ڛkn Ǒ۟Wp@Jutx<7u8?/~3/';x9;Vxw.CcO*IC6uuB&ңOH8j][,2*e"H7mo{mo?I;.ڿ~kWl~tԸ.흾9IQ ⪧n8hBFcs8U+aH 释Nk;?v֧;Ϣwf*hIe=70SmYX*-bp<[ݩ:?ْ?勵iloZ|v47_}ӯud~;o[C׺2_t=~{/[FPȕo}-Kcߨ}:^fKѥ>{#K}N׿ْ?勵ilo^v47_}ӯud;o{C׺2_-~{[FPu̗o}-Kcߨ}:JMKk3f]n쒀͏l竂C׺}u~{ߺ^׽u~{ߺ^׽u~VX|`Oj}qk/~a.߿uo_E]݇MM~}}>}{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺUտ>XCt3k/~^u߿u:gz݇MMt{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{׺*}G70GXߺ^Z{}_ߺ^~]{ߺ׽uz:yOn'k 4A^*w5SkVv}_6WZQ,zqGSTz?^߾νQ:Q:zGߨzG{zGW |ufӵ?j~rA?x4< mLu{{^׺u{{^׺u{&d/9>E}>&:ѿzS׽u@ۿu_v%ߺk{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u06)^kϘΎb;hZ1ٽ)zm$mQS-EL 5fyRIM{ӱ>CVWUt`2ث+ )*뗽]{SLuMOKr0Rm{aA*T{}R4?gu?Iў׺Rhz{(J9=uﰡ*O׾‡T?3ߺ^ Rx~{(J9=uﰠ*O׾‡T?3ߺ^ Rh{{(?J9=uﰡ*O{I!lFB TkHezzVPAV{˫`\mhcꢯv]E R+>q6PH8[ 6bFso _#>g~f$pgwbvHa݅[l|8tv3 .x\0   #ߺou~{ߺ^׽u~{ߺU>X;Syڟ{m~%G_#%׺tu|J*u~kJu'煓B=~}zޑ׿8<4noޣִN;nbآ8)aQsW"\˪rzEoO.7>=ֲomõ2mrn㷅\W4o=$ U \Vw{+o?Mi<#pkY:Oi+;o؅ռf8ϋ4zPb)MjA?>2?ؿx?OmZz1e_*-S?̽x?OmZz Qu[WoςF_ieF{MP{o׿eOe_*-S?̽x?OmZz ?e_>o}ٗ5CO^?c]T[љ{T?}1eO> ٟ5CO^?c.^U[љ{T?}0Eoy"|Tu}}].UvjUexlWQ}9Jbo H,A o\;d{?3QP)GPVf3ÇBM{۾@yKŦ$&&wli$dSP+4:u{{^׺u{{^׺u{&d/9>E>&:7uO]{^ -SԾ:K7ut^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺZE;Nc7.FΊ5Q_;w z9*rmcJjrs3_GI;4éOG-0:'!b29>_f1̾-EUbrTjLetTII 0zS^{^׺u{x׽uz{ߺ^׽u{{޺^׽u~{^׽u$VGUtpU22Uߺ[d"P&ݸ6w?%6*qg;sVϑ][PPp[1W$ywdfcK+6=Lt֯LIQ4tUKU U44Ҥ4 GRU f׽u~{ߺ^׽uZ7a?ǭĿo_#!G:]~׺Lowv}57~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~VVbíĿo_#auw]^1O=y57~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽uѲjQpVVS/.u {t `'pmGcp%1F P4+{3楾\-ش{߯wNKpl _0A4*1&!1Wc-wݯw$5pƯRY4Q^n;.g˰ޥݫJYhʕTj?an 6?LZ??у 6?׿?郴?W^`{<Mu5w`?Oq0u-g^W|d]uAY?`y[ljL#`O[~鵼νLZg t߿A?鴼νLZg t? 6?׿?郴?WV`|Nn~u{}.sYjy ] O:gSE> gʶeWrCD:HMF)O3r_9r`+֓4$FE"Bk\Pc=^e)u{{^׺u{{^׺u{&d/9>E}>&:ѿzS׽u@ۿu_v%ߺk{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^\)֯qv\˲;=},[C'J84a[v*Y*#tA,uev_Ia.+~p7Lv\p 4QT tS5F>$zO USm qhdxmͱN:]'94FÐu ]'/o'u2_ C׼T.]k!ߴG]{w{ ~z/o~u2_ ?^]k!ߴ^w_i={ď2_/oo׼D.]k!ߴ'uex A7_x]{w{ ~~]{ď2_ uK7o^S,Xik>H|gVZ=þv&g*d{i-OfjM?v%7uz,??ᄒպǿu 2 0"7y~}.? '}__ٹdvoBC5\Z1ջ2j5 RWMWӠh$ca,p=m5׽u~{ߺ^׽uZ7a?_u2_X{K޺W t"yWϦ?>>^{{^׺u{{^׺u{{^׺u{{^׺u{r_ߟ?]ul>a.~_&/?}G>{{Izu{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺Ү]rdYm4]ۏI=BMu~{߇^{߾ν׽u~={{^Onߗ|5xz" *~ie/?2?TjՄ?o+dy=Xe׽{{^׺}{{^׺cuy.-xiaKhe~Ji[G]1׺u{{^׺u{{^׺uǻn>&:ѿzS׽u@ۿu_v%ߺk{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺gwo&Smnsm,/]9LVF ,n8 ^IO [KcohK"4Uۯ>0ࢨϷ(zjTkp]~ۏU# #A:-]dEt`]MՕՔ`x^ߺF-B|?Rv7hx`Wa;lNc! 2U7GF[}Uƥ+nn6׷k͆Rd٪2Xw<U)"ʰt{{^׺u{q?O=m~%G_#%#a.~_&7ҿ}_>o_O~/^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^i9/uoϟV. :K6?޽ץw{:g?QϦߺK׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^Ӯ]rdYm4]ۇI=BMu~׺u{{z^׽׺uOߋj{,}^/Gܿ'ЛҧFR/#kN}NYXN_+&ҶOzחYu]{ߺ^׽u~{ߺ^׽uz.-xiaKhe~JY"ۭ=󧮘~{ߺ^׽u~{ߺ^׽u~{ߺZM?_r|7R|Mu{^ -QԾ:K7ut^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~qeWVGP+̬ᕁ=u}y 1?xĦ{x>}=cMPGG+ǽړ^{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^׺u{{^< uԮ]rd[o4ۇI=B~׺cu~{ߺ^׽u~oۿݟXO_]uӕO7O?^G{׼ʝ__bGVMlx' ׽u~={{ϯu~{ߺ^|츷g+ï7޻-3?sy)fnLΎc׽u~{ߺ^׽u~{ߺ^׽u~i5 w+tMLJOA7֍{^ -QԾ:K7ut^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^W|{7t`nLF';ugaa6Me P@;1/6׺+;C_ǽؚN6YOm޳ڙ-]Ti/LL"-%;^1Ê]:~=mSv3Tm3cp*[`#>y憂k|mٻ[q7 V[[G vr'/*:)D`~~鎕^׺u{{^׺YYId*h(i*jJ:Jhj!݂I{^M_𬽳݁O={25{vS9EכI)$͝&nǷ㨌y,|Uj !)3rƝo_x}sʸifۻnM2 rw>w 8K1L*Y9k+zlÎӞmNoA;ߣ3uoda!mM͋2,UT$T f/1ZZ*㩣HeEGd gߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^ֆ_=GE_.8kW.Ĭi 5&[#pcM6+~~.׷t{^ 9RJFSzUbR%d /['$ o>I~3}{ߺ^׽u~VX|_Oj}u|?^c]+U驾ϯϿt{^׺u{{^׺u{{^׺u{{^׺u{{^괿+h~m~%zX{KW t"~ǟMM~}}={ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~ծ]rdYo4]ۇI=BMu~^׺u{޳׺u}{?w~^s׋w?r4&oQ@ t_SkVVɿ]a^׽׺u{{׺]{{^?>?\[{a]Nՙ<E[{G]1׺u{{^׺u{{^׺u+w?m?_KNcWQߏoץ={ߺ_CH^WQGFdbX檲*^TV}И}Ao!Y?˭}u{{^׺u{{^׺u{{^׺u{{^׺uYikC:Kme&\FZj|][+pRckoY*AN*#_;uW^}ߺ_E_Iwz=Ak2X]Y%ݝ#|HuJ޾>^{{^׺u{{^׺u{{^׺u{{^׺u{r>}uAglʢ@1RmíĿo_#uw]^`L_<Ιo_O_~7^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺMU6qT<ԲVi)k 3Cdx^FXʢ<}t{{^׺u{{^׺u{{^׺֮]rd[o4]ۇI=A~׽u~{׺u{{^?nߗ}|5xz" *~ie/??TjՄ?o+dy=Xe׽u~{߈{߸uߟ^׺uCeŻ?_7,3-he~Ji[{G]1׺u{{^׺u{{^׺uQnNՏz/$q4{KWfTOd84n@˧a4zz^u~l z~,|ݟ;C=O;nmg%P،'y ?(k%H7+7]Y PV陖7_H~7^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^ڟ3z.ǐ|`ZE.YR3!-3d6!!ҘWz/)=׽u{u=FZ۫~G."{wfbv[Lgkd!IM\ߺo{^׺u{~?Nz(^\Ǐ.ڮ >,[7zxu#zY׽u%F?udCg2ShU|6c?:;Gr]A7?Zj^RV#-]C+[5TS s螕ƺW'5v=\_u^{{^׺u[۬>|>:KFC?z}c]+U驾ϯϿt{^׺u{{^׺u{{^׺u{{^׺u{*,U嘛~i @v][v.۷nlɞەPdv~+ A[?7LW5k)] j!$NtHI F:'{^gIP7} 'HqUVhsg/qCA k_a3>}}{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~dHtc/po9܂DT;&vfkpR<~^5{ee"5P!]\U Q]yUk)=zq#_gEt0ꏍ?.ߛ}|p[hQt͢As2P|u\6s/e>k|RȮmڟ6@D'Tah"ZVRE7<GU=z'δU͘&VMQnOsnZeZ2T]^eiIU&N GStk[V|6foThVᚃpiן$(+jfR|n^IJl:¥+ëuj??yfKq2 3lJ+kv_mQjD/"վ~]z{ߺ^׽u~{ߺ^׽u~׮]rdYm4]ۏI=BMu~{ߺ^׽u~{߸uz['vſ5wg>o]~_yhMiSDO)~5'>sW,'X['^=k,.{{^׺u{߱׺CeŻ?_7}~,?mYK7_t|]{ߺ^׽u~{ߺ^׽u~{ߺ^T37/;Hi7dgŃݫ6Fk#w>.|_~`ЃkzwuUm7F{eo-]W;_)U'@%E"k2]-ä׽u+22:4MԿ.6*nQb]CnwLKIe!}9N;'  L4 M:\o+GdUPRdOLMtc_u{QGYCRT?FF z߄ +]5Deolz :eolz :W_|7?g{=z߂wAe+YׯxO׿,uG-zc{1ς5Y\IHnGWtƫÏU]_{^/{~÷ije%wcf)c,W6ܱf;#rTIp6RҖ*%B]5_`X]؜pXՁ Y_0>/ZN(П'o1cA_$v61un*$:^g?p}޹ZjxnuWH]45wE+>KBꞎ#j:z{ߺ^׽u~{ߺ^Ю]r,k!qu+;q?^鮽{{^׺׽u~^׺?۷~-᫻?_|;xr+ȟBoJ&K y9D;fa:J?^Oyeu~{ߺ^׽u~>{{׽uCeŻ?_7[K[CVg,~?Rintǯ{^׺u{{^׺u{{^׺u_@)L2bl/Kkpt&IYu=>+޴tZ\Uv>(1ە/M$tXsONuOn?~zQ~׺u{{^׺u{{^׺u{{^_=u~{ߺ^׽u~{ߺ^׽u&Ole>P|؛~V/2[n|+߿ ҕ*# mXRMbؘ$v=zfV8u~{ߺ^׽u~{ߺ_;S| Y6tO-K:׾EWՒoB+"bg֮&*4>(4=j?׽u~{^׽u{{޺^}׽u~{ߺ^}#׽u{{޺^׽u~vߺ]~׺sa3[5[o[q(0[{o`*s+U/ E5fG)"F~ҽ}4y>]|V2m==j.%e|:#[-vᨅ591dd tG~]l!S{^׺u{{^굿oq?_u2A=ӥw}{{^׺u]{{^׺u{{^׺u{{^^׺u{{^ߏ~{ߺ^D $$$տOfi6NrO_J'uBբK+YY&E%w$*sUQUTP**`^׺u{{^׺u{{^׺u*YҠ:,!}^z$wvn"<=DGLͧ JTZGEg tU^4*mES#){Lf6KN%ZQQoшO}]v\Yn~c96UUmSd79MH=*eԄ0F$apA ޺^׽u{^}u~{ߺIٴvO|0ۻCU:\~F <,G(HF]ldq_Vvfݻ&~KT1A.XǎFcă87t'`w8Į?;ޙV4SxɟwE= wdfP:^]{{^׺u{Ѯ]rdYo4ۏI=BL~{߿.׽^׽={{^׺?۷~-᫻?_|;xr+ȟBoJ%K y9E;fa:J?^_yeu~{ߺ^׽{ߺ^׽uz.-ow;K[CVg,~?Rintǯ{^׺u{{^׺u{{^׺u7!r، ^3+A_kZZYZ9bZ9#b${^Do ޛK7D-bjk3}4ʻf3IU[SUȐn}ni#D-cԯ/ϭ93L6͎ŋ &BseJzL2[4SD=ץ=uz{ߺ^׽u{{޺^׽uᄒ׺u{{^׺u{{^׺ '-?{Uɏ9̾?ꟋX& Im54kQ[zOůc]b:iMj?_O_Jl6_X,6S5UCzs9 )VLUS\~{Qǿ<[dgO2qr F)S ) tPt/u~{ߺ^׽u~{ߺEwGTS D4N-]K*Rg>c0UNg? =|oN; tnM0y vV{/SIoWϊaҪ V?#K$lqpA:p N1{[׺u{{^׺]{{^׺u{{^׺u{{^׺u{/;;7KM U,DsH#v5&&6J-^Ϋz][零;oVSm_bc=mƞF5NUIU\}EB $D! 7N0:ڎIKAAKOCCCMRQRưRB ==<(*(tR}u~{ߺ^׽u~{ߺ^׽u~W9/s>z#xw^Z:-%xFaU 杈h𴉹Ah]G]+;| W_o;W v{r m\6?IRdJɚQ_ZfO#XfWffC}k{^1V +pҭB0MWU\ ^Jᨉ(@>@aFjA9:Fe6e8U^~ߕ=ksT['uEϮ&*NhhUِztu)Zy#u Y Pia22̬UՕٕVS ]ku?~>_{Z?^׺u{|&Gmnsm;EdWPTA<:5#~黫s"-~នdQ{OΌxh6>nZ{WysLFFN{PzpI՗taKPmCTv6V7;'3aAKK(7{o5+:бuqCjPOTME5DQOQ42 "c-KVRCq]{׺uk.Em\j$Cmw}=XVݮ/>ιaqUMУ?ơX~t: _G>e7M-? 1=ykjϴwY׿SU׿ѵ?~kO;],)FO*_}^ڟ5'_uECAub/>?mmO?߿e7^O?4ZT?^/bzF i?wd-? 1=ykjϴvY׿SU׿ѵ?~g?;,)F{O*lҠ݋n* ^V7AOQ_w6jidUpXx%1\'3s+u,m2bNGr>Yɾ,"nH*p O+jk)4&]U])>dgSo^_=VmlFwzDfO,I"Z~ʥȾD{~rWm{4WWT jJ:PGOy+ywqK(ehܼ d-@ʙ/b/>?mmO?ϴwY7? 1]ykjϴvY׿SU׿ѵ?~k?;],)FO*_}^ڟ5'_uECAub/>?mmO?߿?e7^O?4ZT?^/bzF hwd-? 1=ykjϴvY׿SU׿ѵ?~g?;,)FO*?_i{;im<u՘Mܕ-iNZSRk%缜ϼi G) 4,r:?tK}|"d9Ji}l~{{^׺u{{^׺u{{^׺u{+i|Bc5c)v%-F v=(M-TԀb"eM:חBXOTˮJmWiv2ك,i'Aye,~3 ^ M4E]_ٿDwPucݛy@i׼s@svo{?}{?WyFOT?rS5tҔ]v_R?o{^1&ivbGbwʽh^ɰDv?_9s=TΝl+6v`x6#I᧡BGHߺoo~{ߺ^׽u~{ߺ^׽u~{ߺU-쎅}vzBzWUfzxHieu1qՃ=Q?d:vMeEGOFvgNS$8WvE[z57fy>uuʹ/( ߨ:߰gK=4s {ӛSg3-(rۗu¥Ao}x䣫a T(s9wxg/xWxyA[0˪6ڻڛ'lI[[ M"~\nMIRxHEߺJ~{ߺ^׽u~{ߺ^׽u~Q/5@?n/"ki3X^O!)hvM1!AKCB0"%L$h#&bQEg kB_sTs,p#_GPuc/fy9~As9{7cucy@i^?:ٿDwPucn sׯx?{=;Oߨ=z_/fy9~A׼s@svoTcݛy@i^?:ٿ{DwPucy@i^?:ٿ< {DwPucn s>uٿ{Dwzcn sׯx{=;Sߨ=z_7fy9~A9NG&jk׋~LW̤iiOoǿPzcM `[)Qw$rѕJ~):B]v_Gj`Pᕅ.esuXu/WtO폈c-0KoRZ4+GEGcIJ$<Ͽt=^׺u{{^׺u{{^׺u{{^U-UU|Q?fcA|ϑ{ҫ#brņ t5G@dP }^Zv٩rwgqQLuEW+?O[N;i7m\c;-]t&xaҋSG1jT8k36A8(xuj=w wRO|ÿǓjϽuߺ^׽u~{ߺ^׽u~{ߺ^e;ƾ=֝}ѶClmZ隶;Z3"+ u+{{9yw7gد.F 2Jԭ E` 3CtOsI;ei3Y"´2+WW6%G^EnI?km?Yo[:6%G^ENx7uI_^G6[O[νͯo~ן{׿<Mei[_?qud^Dc_$$eel|V]yQ9'}{m?Yo[:6%G^ENw7uI_^G6[O[νͯo~ן{׿<Mei[[qud^Dc_$$eel]פ#/&wv)Rvfڛ-:X`Lv-]VPS<+H ǖyg]nܿ{kjX(y5,A!u:+Zysxv` 3+Q؅ZR>;sm͙n߸0Wkm}N[?7&V⨢i2yNz\~3I iHPK=tuogŅO˽u{~d|V҅O˽Pu{~d|V҅O˽Pu{~d|V҅O˽Pu{~d|V҅O˽Pu{~d|V҄O˽Pu{~d|V҅O˽ӯPu{~d|U҅O˽Pu|>YdTUPYBUUbIPN?!Ai2x6CYA*hh)JzJyH䍙2>׺N7V͌oMӈPV%eKUY"puRZUB\=ӯTz'{^W?O pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~>л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~>л~{*mvCת=zUB\=ӯTz'{[W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~>л~{*mvCת=zUB\=ӯTz'{^W?O pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*}vCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~{*mvCת=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>nׯ^?.ߨ}:G^Ja?b]뇿Pu^z~>л~u{*mvC֪=zUB\=ӯTz'{^W?lO pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~>л~{*mvCת=zUB\=ӯTz'{^W?O pNQ׿үX؟`?>zׯ^?.ߨ}:G^Ja?b]뇿Pu^z~6л~o4vv7Ss#۽+6}M rM$*YB.+RIʠdYTcOZlmCv8rReY;rӱ/QʪdKIUS#IpUGkҫ^׺u}{{ϯu~{߈6pmɉn,F/p`p|7brUj)*SCcߩQB*:$Tz ;O#ta>7oSCRLꗈ~jeMժTqux4oiNPyҴnG1Vz6͡}kxWR:sW8ÏH6̳TG4L\LVGCG_t$`U7VVI%уG,R(hԕ9 r=ӭӮs׿׺%Gp̨̈5;* EOunCӫ&~w_\nvq=_q<Nj(>QzW<UO1?$=u}S k갔a?E;q4),:e??Gnzv]7x|TEwjzIԤ+}IG&>0Y\F.ލ>Mvct[/Ym= Mq;hv]7AF{ۻb:5 `d*♯Gߺ^׽u~{ߺ^׽u~{ߺ^֟TLt dF?/ =Jm!#ZkVt@<^? ?ϧyiT_xa0Ԩ~:֕:JMG~ν8R}SWGo ?)?{,zG_-?~o^ҿ?g^aQѾ޽E:JO7ߵ7~ίG=צ4STU6uxzm,*M?{CVg,~ sz$i"ۭ«+J[rVfd7|t|KBEG)HtE?}SԈ~{Rӈ~utMR"}uQʭ7H׾ΏU)D_ouTMR"}uﲣJo{Y**? ?=u maoxuV1QȍJ~k@? b}9xRﯽZ (ԯ?=Tk>׫׼Q_ߺO]xP퇽ꞻGz={B^Bz={m}jxPOSST^8+{Z]P?z^(/o~>{mzuB^пT={{^^G{^u3׼q_ߺO^S^8/=zq^?5]{п퇿u-uQߺO]xPӯTߊ? ~>׍z? ߺO]xR?Ázq_N^BNS׼q_׳׼q_ߺO]xPTӏ]P퇽uꞽJ$Ba]zxPzq_ת}z{^^?g^пߺ~}xGm}u_]xR퇽ߎ? ޺z? {^8/o~={mS׼iꞺ?o~u? >תz? ߺO]xP^׫WS׼q_ߩ׫׼Q_׫8ԯozկ׼q_}zxP퇽u?/o{={m]zP퇿uꞼbB^B^#O׫׼isz>BS׼I{:O^G~=uBתzmT={mzxz{ğOתz? ޺O^G^8/a~>{mz{@mzxP퇽?+O~>{{^]xPzQ_׫ꞻG{^? ߺz? Wc޺OUs)#rtͱ7S=@ Mݍ|Оx9Hu>&LC&}(''gKk?.u~uߟ^׺uïu~{߽:^N׽u+CYQQy!ReRWP5-]gϻs{߱5섐%Y6lck[zӫ:bap(,F+ 8F$7zӟ'{}ko]e޸a{tTywzmxH3uxJ,t~^ǟd$d3Ko#i|ϿuJϯߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ]a^׽u~{ߏ^׺u{qnW__w;[[CV,~?SMWۯ~|/?|C_uOпUz^uߺ^^׺u~׺ud_PUO~},1|r?'U?(},6n/MtY}۪uB8h|P-z/mt] 6l+XlcsӥE.0kK5q ȠoM)Ҩ b@'.{+NguB?}u_?[?̫|n;V[(붶gpd5U5qO*< xȬǏvV-\t԰5z _~\۷:Gq_XxOrlV Xi?iL.БN%j9%vH#j vJhQ$쒆'oz>][G.7e|f*bLrt) dvF Q5b<9`t۲Q++::IIIȡ9#fI#ee%YH }ߤ!7! ]Pri{zPasTScx,|QڪjM.{4(=OTvoo[zian uZڹ䈣',OHuWiNIE-׫Ot=_I}ٽ(6aFݐ57jmbk(SSicR=]QEOZ'Je@t84D=_;0J6ۮ`fE5]v/:RƒS~΋YW.Wj5/UQHdlBcϟW?_7N}4tth0&u0RM.*ܕHM<#J;QdgV`o ΒgY?μG߿u.k{^^׿~]{u#~]^_^ֺuu#׽uoo~}u{~{ߺ^|޽u?~={Zߏ׺u{{^׿.{{^׺ߺ^}oo>ֺߺ^>׺u{~S^}{Z^}{׺uׇu{{[Z~}{uk{[uu׽{{^^׺u?[z{]{uߺ^{{^uosE}u}|u{Z￧u9zsw6Ǖݍ?lu[;/wA&zYMVG'PSJqbXX:dC;o1[9۷5[SS=͑ry`ȆB(O!Tdvs!:\T׺Su{^|^׽u~^׺u'ԟ?Tyoݛ)GQ]Z.٦6O[{;rCbRO>z<2V&BMn\ڿ/O??AJߺ^._/{wޝ{Zwg|X.2}ҏQCE]ʈ}ied>I#хC=[/?>-'jo뷞LմqtU9zKSQBi_ǻRIiA=e~vaݟ/UC'WƿtnΎ{X M;3; Y8SekȞUiq<~uv˙Pt6̙YMoeiu>O7U o\o,noru8^PVmlNN vK ]T#sФp!PǻgTi?G<7tdKvJni$v`ir8(̾ c%d %tҘ*uv?#_{J/~>[k +rPT*:fV6'bOE_I5ipGdUGav<I}N7#~ُ:]?gn/aE&~B쏋]){3͇ڔQ3 M*Cݛ$mO<2 / cib2E*a#K"׿uuu{oߺ׿{|}~]{׽:޺]~{[:u{luo~_o^}}ߺ]y?u_k׿{˯{[ֺu{{^׿.Ex׽uz}{}{>޺W={[ߺ^}{[ֺuzuo׿u{{^׽z=u}~]{׽u{[ߺ^uߺ:u^u?[ߺ^u^׺u׽q׺~}{~=u~~{|}uﯿuUJ'U&[7\.?WSE>*I EU˞?]1t#8oE{޺^{ߺ^={{^׺Su~{߽:^ Sj39|.ܵ"?'(^Rmll5YjdžB8٫^,vUIpFIeTk+-4yydf|m4m(]GgL~:ۼM{Ҹ0kWdʵN€=dף){ߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ]a^׽u~z^׽u~{ߺW ݟ{zvXuv^U_r~LĿh<z]/~{ߺ^׽u~{ߺ^},[ I{Wŏ&/_}s􃪵ek1y4E:ҋsՋý>#хC=\~,WoX鰺w>>~R/@)4TRVąŤ7aAxdfbc?(o/}z/i~5|:'tf)_-c_F+jL§㿏H{ ꌌ)^8}?zOqG&݄oeiuON7OUbGY($`}7~>ة]gv5W`Rv>QTQWv9N͏Y 4঒M!tMEt Z} ε٘c`(7>w,!d:]He|^9A|*W'G?i8PʅSM].6Gz}y̆W:sc gmIOrJѻp{uX8xO#<Km |:4_ȣNjt?E>L_glڈuԭJ,;)0I]>+.^yu}?}&=u}{^׺u{~?o{Z^׽u=Nko{]{׿{Zzu{^z}ׯ{^ߺ^}ߺ^{^zu{{ߺ^}u߿u^kƿ{^׳~׺׽k[k_}u^O~}{)kOu__<{[~]z׺u??ֽ׺W~^{ߺ^׿#ߺ^ׯuu~{ߺ޺^׿~G{^uo[ߺ^y׿~돯ϯ{^=u_~}u~}{׺u.TMcny{'iQvjϺ4k`JK~8'f˭['5r7'bn܅F޹˒[W)EG1-d᢭z+OF//ˡ ݺo{^׺Wu~:^{Gu{{˯u~{ߺ^Q|+4syKG_pM,RycBKz}]I@ѽZ"Gsg?A_,׺u߽yu{C7]gs)I6A]cak2F/Wu^U>]HuqO^#׽uߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ]a^׽u~?>׽u{{޺^|츷g+ï7޻-S?sy)n6nߟnO:]2~uw\u{{޺^׽u{{޺P_n*'u_?옾9{>}+ۋ~=_vꇭ(o#?coOCG%.^^gT`ݛ7\eLHbJ9*LSQB]Owx>KSYnv_0l;B?E/wj'OڿV3,M4V>Aϟw:F]dl>ogiugׯQmDKٹ(aEK>iiHQ@{\tώ?˫ M[GFyj49>ee5sX׺~}{ߺ^}^}~{ߺ^׽g]oˮcׯ߿u{{[7ZOo{Z?~]{k׿=|uߺ^{^ߏ߿u{{^׺uu{~{{^￯{[ߺo{Zz{Z׺>׺u~~]{ߺSߺ]^?~׺uƽ{{^#ߺ^׾_~ߟ{{^zuu?{[ߟ~{kׯ{{ϲֺuߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ]a^׽u~{ߺ^׽^?z8x޿׺[h'?촾^~?67%|G(Or:%JU֎%J*T9+a7o'QB#Zň}WyT>w|ߏux4zC:*M]/6W[[EEǏZ?~R%ypC⍊gpy ų'p-eUZBT{iһV)z?G Fܟ7vVɊf7Pd\Wv<\< ' e"]榪eyp1__ntϯ{^.@M׽u[Ͽuks{Ϯ[ָu~}x~]{?゙u^[ߺ^׽{?|=y?~]{ߺ׽u{}{ߺׯ^}"׏u^og{^ߺ׿~]{ߺ^׿u׿h~{׽u^~=kӯ׸u=u~{ߺ^}~>~]{{׽uuqo׿_޺zoߺ׺u׺u{{^z{ߺ^~׿_}׿z׭o^u{]x}}u׸ukߺ^׿^׺{wo׽u.ظ.{%VbJ nk5뢛 q7SOAJ@>u*@.mo)a]vhd :SS?MM'ձ{x48x&?Dj|OEI> ~]{ߺ^u{{׺u]{{^{{׺^Z|c{v ]C. kn|lRfz]^ѫUd׆N]W/z6DfCŸ}잁|=޽{{^~{ߏ^?š//h,w簿z~ts2~ż}sMvT;#[jE%}~ntKjH@@67êI PcCݺduya//z?7O֟`}8o+ozu"vdޏjq c]ٟu[Ϸ/&^"zzec!w)*ޟBd:ay7QGUM%M, 3)mX:86_.75{kf7 fne6scFǴ[IR#Vbݱrۓ!CTڽ^9XPtlLF2N2ύ9Z)neT=Jk+'ZcԘznVR7P$szצ\~ު;Odz碰| tcmՌ3K3Y 48斪D%ZAd5.NKpl{=ݹ oiגOzEӿu{_~{ߺ:u)Ͽu{ӯz׽u~{׽u{}{ߺ:{^ߺߟ^׿׺5}>ש:u`~{׿uu׽u{a{~}w?[ߺ׽u{?1o{Z׺u{{[ֺߺ]}}u^׽:u|E׽u~{z{ߺ׿׭׿׺u{O~gZ׺u){oϿuk{^׿>?׺u~{?׾]{uxx׿}=u~o^׿׽tN[m5kbd>vK?1Fng'Pn.5R!j:3Shd6FUu,*2ZE3@l2mLuy|,ǵT 뵪of;/=MzXUK=bLUxHKvuN{{:^^׽ӯu{{޺^﷯uu.׽tOftX$ ]QGq 6yfbm,`d"[~q# .3,x}TN SEO_\\Dՙ]{3Y>Wqf'Ld` $Nz>`t\:]^)׺yuJ|&/!yRTԱՕM= wTAO"=uUj~|6뮿0SvjYSCG]nZMtF] ubֺu{ߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ^}a^u~{ߺ^^׽u~z^|츷g+ï7޻-3?sy)n7nߟnO::|uw\u~{ߺ^׿~{Gu{Y/WWh_hL_ljUk} +ۋtT>X(a޻svfSvQm)im̦66 Wd+8eYtd k^I(Pϩ&{;@=?Ͻxc7@7gه#־tw -g{o;cvNB OZiUu<((SpoʺznI@S.}ۦHg޽}{w!{?+ݗhpyhhALZ*~}Р$nT.i"{SjH*dj퍻 4jv \FZ8;"@6ruz׽t_XwWPvoPr fʭPSA[]= JJ_RV?SDu4`ޝVŏן;c lms;Gm1{' hrm*S>SNΥt/?w?^_ߺH.޹m{{l̸oJȬR?xjd:85S'?oK:Iwթw-ݍh˛h_4{*5c?Yٌ rw(?ˢK VUAg5MobSf?=o=})uE}܎(% ܔo`S ٸ.~B"8t;W"iQGQQE8U8ER4Er׿}}{~Ƚu?u?~=q׺׿~\:uۏ~_u^{{^#ߺ^}oߺu_~Uzu}{}~׺u׺_~}{{}y}u}~}{ߺ^O~}w^ָ?zu׽u߽u_>ּߺǯ{Zso~.׽u{^^׿o}{~m{?u{^ߺ^׿co{Zu~o^|?[ߺ^}Z^{Zo~{߿uuߺ^׿=|޸׿[+~}z?ׯߺ^׺u^ߺxuoߺ׿{^?=u{ZtCu_r*rbnouv}Z}6Iau$VҟˢǛϑ]U}YOccAvܓv~biW b˳xmN p0Po??M/vNW19 ^&]U~m/b}5&W swR T TyHk^ }}{߫׺u~{߼^.={{:^{e k=45ыu>Udp]XFKJF[i@7k>߿u:^ïu׿|V=~-[c.wO0پx|TSNǫҾO{*7 H4IJ7֏:u{{^ߺ^׽u~{ߺ^׽u~{ߺ^֟O)~5?sW,'\ɿ]a^>׽uޝ{{^׺u^'ˋvo_:3}?Yc9ҚoHconܿ󣮙~y?BG׺^׺u{{^׺]{Y/WWh_hL_ljUk#}>%W>_tT׺#ߺ^}o={ֺo׏uoߺ^x׿ֱ׭{{^{{^Gߺ:u^}o~{ߺ^}[ֺu"#ߺ:ߺ^׿Ou{=u~{+׿ïs}k{^ߏ[׼}o{_^׿u~}{>׾޽~{ߺק^}?oqǿu~]{ߺ?>E{{^ߺ^׺׺o׿^׺~O~}zE{{_ߺ^u=uߺ^|Guϯ}ߺ^~{ߺ]_}N"׿׺?_~{{^׺ß~}{~C{^{[{Z׫׿_~}{7׽u߽u׽u׺uߺz]ou=|+k{^{=]=aܘ<df|S ު^Vm-㆟6j1$z=Ձ#Ϣ>u=sa r{/%nj^|sixӈ4xڧv7\:7r>ORg~Γ[W˳*Fgdv=$m-wW."}N$d[jA~|=+1dGN}WIg3u2EAvmö'DGޝMSL6.DQOzS*ղ }NN~][Gu{{^׺ߺ^׽u~{ߺ^׽u~{ߺ^{@[zKC;Ŷ[r3[Ľ\͏jMlOد9V{N[K+i_[R Q1&suŽ3եIhÕZH''=_z+@LOz~{f;>m?&'{M9O{O/E ^~{f)7p/^x_b׿{Mk ׿"W7n>m?&'{M9O{O/E ^~{f)7p/^x_b׿{Mk СԿ~.t6ztCZnʜMVpm CMIWL#QTBB){%߽nh]yd#BPOG#r\ʶVWabD=Tzt0_l;'k᷶X,GqQEnMz</A8hk(+dh十VRAg}1*1_>W#ߺ#׿ᘿ'Ϳ^=x]{R޿.ߺ׿ᘿ'Ϳ^=x]{R޿.ߺz3|]Yǿu1*O{^3|]Yǿu/ >-H{|#x9{^VE6 :ج~iqxM$4uAICENFE}=t]//UXzʅ:jq,ΥCOG֨=:deϢlѾN˟DϨ}SzN˟DϨ}Qw˟EϨ}QG^eϢlѾ#Ӯs#zӮs#{H\'}F'ڏ^O:O7ߵ7^O:O7ߵ^AW:O7ߵ^A׿s#{HW:O7ߵ^zu.}>d玓Mר=:>Q?IFר=:.}>d玓GׯPzu.}>d玓GׯPzu.}>d玓GׯPzu.}>d玓Mר=:.}>d玓Mר=:>Q?IF< ״N˟EϨ}QG]?6Gx?~޽zӯ?6Gx?~}z^eϢlѾz]_6Gx?~}z׿s#zӮs#zӯ?6Gx?~}z^eϢlѾz]_6Gx?~}z_O:O7ߵ7^O:O7ߵ^AW:O7ߵ^zu.}>d玓Mר=:.}>d玓Mר=:>Q?IF֣״NeϢlѾNeӢlѾ#Ӯs#zӮs#d玓Mר=:>Q?IF֣ר=:>Q?IF{>Q?IFר=:.}>d玓Mר=:.}>d玓Mר=:>Q?IF״NeϢlѾz^eϢlѾz^eϢlѾz]_6Gx?~}z׿s#zӯ_6Gx~}z׿s#{H\'}F'ڛׯPzu\'}F'ڛׯPzu\'}F'ڛׯPzu\'}F'ڏ^\+}F'ڏ^=:>Q?IF{>Q?IF{>Q?IF{>Q?IFר=:.}>d玓Mר=:>Q?IF֣ר=:.}>d玓Gׯiu˟DϨ}SzNeϢlѾN˟EϨ}Q{>Q?IFר=:>Q?IFw˟EϨ}QG^eϢlѾ#ӯ_6Gx?~}z]?6Gx?~}z]_6Gx?~}z׿s#{H\'}F'ڛׯPzu\'}F'ڏ^\+}F'ڏ^=:>Q?IFަw˟EϨ}QG]?6Gx?~޽zӯ?6Gx?~޽zӮs#{H\'}F'ڏ^\+}F'ڏ^\'}F'zׯPzu\'}F'ZׯPzu.>d玗Gׯiu˟DϨ}SzN7v. HY,-_r[k?Bԙn6&IO[Tgv(!Yک[N'A|E(3]|P5K$@;\6G4=Jˇ7UU;CzEݽCԾAMݿl峾&)-FU6?hc*vS&~ gӤZV?>$0*A A~۝1^׺|^uk;vSc`:6헦3oᤩ̄e{]GWrdF>ѕT 1p>?t]=Ǯ׺׿^z={-?:/! j~A$^Js4RmM\ "vocyy;Z4=}u~{ߺ^׽uߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽tKu~쬏\_[Qzͳ6;p<8k"A3cBtU;{G Y>TO?9ک q]qްCt7ubM,bLw2& ?X":!=S^-u';5;dbÞj*() RwbX=UEPtYFӵfRFSҠ>"x׺ݵ;Jjwmn>MؔSۘZ͵@rKϽӯ}XV'Ov}j3]ڻw ULE}0vWU7Ttu^k9RU)5cVpWQC;K#&'L#=^zuv om -_^=k7ܣlRm a'VPj둛޺5{Z׺u{{^ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ@~NE9-{mOւG 3m@R17+pmw&?fid7%WO8V 8!b*j)Dba]%-'S(<[l^;n0[tҽnYz\_Wap]ߞ콩+qUێ=y)1yUV2R~f}/:xoM)D;7<-[wFkl2Fn~s:]Q=XW*/凍TwH۝R$Ӡz;iJ$.5wGq#XGcӭWWP: g]w^NɚJ*MI7?Gӷu{{^׺u{{^׺"7C֍m5cy &I@=7C֍m5cy &IN+Z+_.,8X}*+x| XsҨ!CrMQ4dJҀTQMM\!CDBRYʐҨI$D~{ttOɟc߽^k@M`J'*Ԩ? CJ, 0JT9T,}ޡJ u QB݉Ƃ(χ+_t~lp[}Vm'QO9/y!=/)JE%OcRG/a@sEO{N~#+t$ w3===0zyA:Eiҫm\"(q/UTU`RP1N%uRO38HX-݃&ܺC\yhh HcbaΫ1 ^L3K/L N6).Gcg!Ǫ@UgȺ'8m٩pbMA69Fٰ/t#2ovo<괘|<+]bbb e)?.mzCsȑ|׏du0zވ<2?,_a" ]n,WӔ3V<i1&1?b19w(su#I=9CAWL|<EiC>/GړaPG/H7n\yXVGw|D a' @c 6B_TI]@S/D[l s qu5dM>j#JIq8ẝl4W/ʯK$5u; +BFj"m!}!qγ/yzYMs1񁞧dϤ__&S_eL/kczz8x!qb-">Q&>6Hw[~/;*3lm [gswLf #V,VTbƂ[YP&D?ñόTA[c e''Qr>m82z><yRSklgqLt1uFR'/6x=!! [L$|Yю٠5ND%Um"%jelK[όz{ۉl͈6bųFm%Pľ2?2c'&з/>el}eaoA^L{i<̛]o0 d< B|>d"}Th⾊GcExW&nAw8R#]VFDL;3H1O,V=!F?Ì' b'\o캍]q_Ic[etH0o>tb"C( 2 R(^vFeoo0c ^P'b$/ #yI +8#l&fDLdCDdMv7e2w9)fsO;F`#T:~0gg.D.'+05Ȅ,xDaCY&` )߱r"e>Df'!Ğl2T0e(U23N&O(bF Ld!kBLd,u@;O a$oY"+m%Kz^(I6pђFDN6- nx3#Vs z"QŚ8Z=-K)d\2P39R`rNf>J?}Plgg%A-A& C]A`1LA eP eb"Ê_˵H Ȱ_<$;`)cu2&Ϭqչt; 6EChoa, gS~{Ծg̾qY9$^PWv01BDf &u?'~>3ǾK#3QDI84',CM}|xҡ\a(kv.[ɂUذV*vĉ(/^Z+X43ifwZBwm6ri頪jk-׫bB^\cNO;ǚ-~{ eoE2jμQ$--#l틯ik'R iě WWl9番[ؾOywr{j_/< z0EqysLQ7"x=爉>ǣOcwvNi.qL 2B_d%s N_i1I#f]}:O&b"wc\^D{oѪ{^li8L 8'.[_)랢cR URT62M7Y]*B싹)5mϯۏ~{Zfr?o,6)r2ŋQֲ{uy|V쬷,PsSL&7vfjz;Ŏu^ND7ݨ+{4لoRp_WIg&))_>]o'e+yv0X{;JF~G۽pd N~py#C?f[v?vcT~-BsN:eʮ}aaz?+JW?CR7 \#1gܻ׉x^y2Cyٺ1?Y~?g?J?,ƹzdsWu V:r4tmKW T2۽CVйkOM^;6H{u^I]9+恻*>JbصT]䯄ϳt̝2U:2H6(_UgMebMkkw +j?UϜwD"xDUQdYyTY~WŊ{K=һzߤP(F[DfOڴFۜGk ^>9!nxιR=)Ս= 緷e5v=IKb}%r2z!12RwPT~0{ӧ%YS脟^u׏/9{9cm_/̚þ3ۄ?vw9N1\3ElVTNUGǭfp%$e4Tʪ|9kݦYjŮQ/j|V_?S]^SfN<$gG%T-z^]D)mkyf>[ۘs,߶=<V;;yDŽ0V2yhɺ)Jk ->Ǣi볕Oӧi^>B436S+ߛiN/왟ybWO\3zG{upHM[mrWˆ{5 va[ɚ,>tKMRY@Ʃ@ӥ*WUƭtk6.e;r-F]y6.0#=9{׌ jZK5}BԬ9ŗ.:<>]z|r0+DL+q˧珔\5w{9FtםVKa`[EOKjoe}uAҦX' nrIi?eCæ ia׎SO5upK<ؙV{:*`]ְ6 ', ֱ*KM ǽñ1z Gb T4o-Or_/ckԢpʾ.duWT>-%#E\qR?1k3vDI({O'kiTjBO/" mYhEASK+44 ] MPRWw|PRCKe@Uq4CK{;ⓒ Z0^ArT7Z`ѢE{^oDۻ ;Ad&AcGkH*辶/ 7d.@}k'T~PO(U#^-P Bl 8?q**jꠢj;>Cqx^{ἑ?u-:QAcD<ʪj=WQ ^}xs*Z!SZ7lo]ݠT9:AǧnHHN@uy**и.mgIP ?Np HLI*4(UA9G~Q$'ARb6ddAjz dBai%:?ҥG'HNKG!+QQ^~ C`8v2sKXkPJtNCeýPVSR^ ^BԳ $O-C񨆔LԮ`_R ٹP Q-*a#`/r ߡ*ʡU߽ED@c wP%UXY`fp9 JHG2V *( -~ca"b#ݺ<<<=s MV>Jyɨ4TWi963 >-O~:=j~ȶ5$777||+}_V_QYUSHJNy6)+;'7*)"N/^Ƽ{4);wN B$ixh|v= FP͐[.8E#=Ϝ>w>._9~G'gL.}ǎ:y m-Yع}u6n20ܼTCL|+*2SSD|JUh\HN~ (p2tԝE9s%;e,\ĉ.4CTL\b$I Hl$9aS4ai",3NF+s,YE`7xǃsÆ.c)tR؆9N.":̰=mK%~c Xo,7c ` *%XCϣ C,!JJI"ߛ \,OI%%{: 2` A>X .̰a M6cw~@ ?u'pA -^P_fBBl%AB\'@iy-_E\6@>uC5j9+fZd|qk[;h UHoW(Cc+,ȅP.a uHC(A-s.ʁv=H| %-.S]6P ҳrc%5 w9tlupسf>p;(EA⟚A֛#p| K V UՁ/1r7@!/Yydo!Cث%v@jz:044ntZ==H΅>. Z[XmǸ&?8-D]!8wn$gׁNAv}V{e[}[y zj8Tⴘy9 3V: iDmu3 A@@    ResearcherTitleJournal ReferenceYear"Maguire A, Blak B T and Thompson MwThe importance of defining periods of complete mortality reporting for research using automated data from primary careyPDS10.1002/pds.1688)Mass Gonzlez E L & Garca Rodrguez L AuProton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational studyAliment Pharmacol Ther 28(5):629-37"Keenan H T, Hall G C, Marshall S WZEarly head injury and attention deficit hyperactivity disorder: retrospective cohort studyBMJ 337: a19844Petersen I, Man S L, Evans S, Gilbert R & Nazareth I+Antidepressant prescribing during pregnancy2Abstract, The Society For Academic Primary Care, :37th Annual Scientific Meeting July 2008, Galway, Ireland (Dave S, Petersen I, Sherr L & Nazareth IMUsing Primary care databases to assess incidence rates of parental depression1Abstract, The Society For Academic Primary Care, GHamilton W T, Lancashire R, Sharp D, Peters T J, Cheng K K & Marshall TcValidation of the CAPER score for diagnosis for colorectal cancer and comparison with NICE guidance1Abstract, The Society For Academic Primary Care. -Molokhia M, McKeigue P, Curcin V and Majeed A{Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991 2006PLoS oneVolume 3, Issue 6 (e2522)0Zhang H, Garca Rodrguez LA & Hernndez-Daz S.*Antibiotic use and the risk of lung cancerCancer Epidemiol 17(6):1308-15ARait G, Walters K, Bottomley C, Nazareth I, Petersen I & Lliffe S8Survival following diagnosis of dementia in primary care937th Annual Scientific Meeting July 2008, Galway, IrelandJHamilton W, Lancashire R, Sharp D, Peters T J, Cheng K K and Marshall TPSymptomatic colorectal cancer: risk differences across age and between the sexesAnnals of Oncology SubmitteduThe importance of anaemia in diagnosing colorectal cancer: a case control study using electronic primary care recordsBritish Journal of Cancer98(2), 323  327%Margolis D J, Hoffstad O and Strom BL\Association between serious ischemic cardiac outcomes and medications used to treat diabetes"Volume 17 Issue 8, Pages 753 - 759IBlak B T, Mullins C D, Shaya F T, Simoni-Wastila L, Cooke C E & Weir M R.?Prescribing Trends and Drug Budget Impact of the ARBs in the UKValue in HealthGuest J, Clegga J & Helter MwCost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK%Current Medical Research and Opinion Vol: 24(7) 2008; pages 1841 1852@Langan S M, Smeeth L, Hubbard R, Fleming K M, Smith C J & West JkBullous pemphigoid and pemphigus vulgaris -incidence and mortality in the UK: population based cohort study 9;337:a180+Molokhia M, McKeigue P, Curcin V & Majeed APLoS ONE June 2008Volume 3: (6) e2522 Morant et al#Master of nothing but knower of allInt J Clin Pract (Editorial), May 2008, 62 (5), pages667 676.Zhang H, Garca Rodrguez LA, Hernndez-Daz S4Cancer Epidemiol Biomarkers Prev. Epub 2008 Jun 10 2008 Jun;17(6):1308-15'Gulliford M C, Latinovic R & Charlton J=Diabetes Diagnosis, Resource Utilization, and Health OutcomesAm J Manag Care 14(1):32-80Morant S V, Reilly K, Bloomfield G A & Chapple CDiagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UKInt J Clin Pract, May 2008, 62, 5, 688 694(Vats V, Morant S, Chapple C & Kelleher CIncreased Sexual Dysfunction in Women With LUTS, Including OAB, in a UK General Practice Setting: Analyses From the THIN DatabaseC23rd Annual European Association of Urology Congress. Milan, ItalyMarch 26 29, 2008MacDonald T M & Morant S VpPrevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United KingdomBr J Clin Pharmacol Feb 2008(65:5); 775 786MacDonald T M and Morant S V(British Journal of Clinical Pharmacology65:5 (775 786)Hall G CNValidation of death and suicide recording on the THIN UK primary care database10.1002/pds.1686FBulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando D J & Idris IjAge threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetesHeart(Ahead of Print)@Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J & Brindle PPerformance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation studyHeart Jan 2008; (94): 34-39 Morgan O, Griffiths C & Majeed AnAntidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993 2004%Journal of Public Health. March 2008 (30); 60 - 682Smith C J P, Gribbin J, Challen K B & Hubbard R BrThe impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK QJM 2008 101(2):145-153NArellano F, Arana A, Wentworth C, Conde E, Fernandez-Vidauure C & Schlienger ROccurrence of Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom@Pharmacoepidemiology and Drug Safety, 2008 ISPE, Copenhagen 200817: S109NArellano F, Conde E, Wentworth C, Schlienger R, Fernandez-Vidauure C & Arana A'Validation of cases of Lymphoma in THIN 17: S87-S88Blak B & Maguire AoInfluence of affluence: The impact of social deprivation on mortality rates in THIN, a UK primary care database17: S252HBlak B T, Mullins C D, Shaya F T, Simoni-Wastila L, Cooke C E & Weir M R Value Health2Carnahan D, Haynes K, Sammel M, Holmes J, Turner BbDoes an increase in serum creatinine after starting ACE inhibitors influence their discontinuation17: S277!Carrigan G, Khromava A & Holden W2Changes in the incidence of encephalitis in the UK17: S253Gao S, Juhaeri J & Dai WS>The Incidence Rate of Seizures in Relation to BMI in UK AdultsObesity (Silver Spring)Hall G-Death recording in a UK primary care database 17: S245-S246/Haynes K, Schinnar R, Wong P, Strom B & Lewis JfRecording of pancreatic, colorectal and lung cancer incidence in The Health Improvement Network (THIN) 17: S38Laudati J, Motsko S & Jones JRisk of chronic end stage renal disease after use of ACE inhibitors compared to other antihypertensives or no-antihypertensive use in a cohort of diabetic patients in the United Kingdom17: S233&Maguire A, Blak B, Thompson M & Hall GaThe importance of defining periods of complete mortality reporting in automated patient databases17: S250Maguire A, Schwalm M-S,One question, several countries: understanding health systems and standardising recording habits in primary care databses in France, Germany, Italy and the UK17: S279*Margulis A, Rodriguez L & Hernandez-Diaz ShPositive predictive value of computerised medical records for uncomplicated upper gastrointestinal ulcer17: S126;Meal A, Leonardi-Bee J, Smith C, Hubbard R & Bath-Hextall F4Validation of THIN data for non-melanoma skin cancerQual Prim Care 16(1):49-52Meropol S, Chen Z & Metlay J7Adverse events associated with pediatric antibiotic use17: S273,Antibiotics for upper respiratory infections 17: S209-S210(Rodriguez L, Tacconelli S & Patrignani PRole of dose-potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population17: S200,Schembri S, Morant S, Winter J & MacDonald TInfluenza and < pneumococcal vaccination protect against all cause mortality in patients with chronic obstructive pulmonary diseases17: S194*Tennis P, Roskell N, Andrews E & Rothman K;Risk factors for thiazolidinedione related peripheral edema 17: S118-S119RYuan Z, Weinstein R, Zhang J, Cheng M, Griffin G, Zolynas R, Lee M & Oppenheimer LClinical outcomes associated with anticoagulant therapies in patient with incident heart failure: A retrospective analysis of a population based database 17: S1-S294,Pujades-Rodriguez M, Smith C J & Hubbard R BYInhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary diseaseQJM 2007 100(8):509-17Cooper SC, Graham P, Trudgill NkRisk factors for the development of oesophageal cancer in Barrett's oesophagus: A primary care cohort study Poster 2007 8Kell P D, Hvidsten K, Morant S V, Harnett J P & Bridge SkFactors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UKBJU 2007 99(4):860-3TTata L J, Lewis S A, McKeever T M, Smith C J, Doyle P, Smeeth L, West J & Hubbard RB^A comprehensive analysis of adverse obstetric and pediatric complications in women with asthmaAm J Respir Crit Care 2007 175(10):991-7<Bath-Hextall F , Leonardi-Bee J, Smith C, Meal A & Hubbard RkTrends in incidence of skin basal cell carcinom: Additional evidence from a UK primary care database studyInt J Cancer 2007Nov 1 121(9):2105-8'Coleman T, Lewis S, Hubbard R & Smith CiImpact of contractual financial incentives on the ascertainment and management of smoking in primary careAddiction 2007May 102(5):803-81Currie CJ, Poole CD, Tetlow T, Holmes P, McEwan PThe outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysisCurr Med Res Opin 2007 23 (1): 33-9!Davies A R, Smeeth L & Grundy E M}Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005Eur Heart J Sept 2007 28: 2142-2147Douglas I J, Smeeth & Evans S JPA propensity score controlled cohort study to investigate the effects of Statins)Pharmacoepidemiology and Drug Safety 200716:S1-S274 (474)HGibson J E, Hubbard R B, Smith C J P, Tata L J, Britton J & Forgarty A WsA general population based study of the impact of prescription-only medicines on the risk of road traffic accidents16:S1-S274 (59)Hall G C & McMahon A D_Comparative study of modified release alpha-blocker exposure in elderly patients with fractures#Pharmacoepidemiol Drug Saf Aug 2007 16(8):901-9070Jara M, Lanes S F, Wentworth C, May C & Kesten S9Comparative Safety of Long-Acting Inhaled BronchodilatorsDrug Safety 2007; 30 (12): 1151-11605Lewis J D, Schinnar R, Bilker W B, Wang X & Strom B LfValidation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research$Pharmacoepidemiology and Drug Safety2007 Apr 16(4):393-401IPoole, Chris D; Tetlow, Tony; McEwan, Phil; Holmes, Paul; Currie, Craig JThe prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis)Current Medical Research and Opinion 2007 (8) 41-480Ryan R, McManus R J, Mant J, Macleod J & Hobbs ROThe prescribing of statins and mortality following a diagnosis of heart failureAnnual Research Conference - West Midlands Deanery, Department of Primary Care & General Practice, The University of Birmingham 2007May 0Solaymani-Dodaran M, West J, Smith C & Hubbard RPExtrinsic Allergic Alveolitis: Incidence and mortality in the general populationApr 100(4):233-7WTata L J, Hubbard R B, McKeever T M, Smith C J P, Doyle P, Smeeth L, West J & Lewis S AdFertility Rates in Women with Asthma, Eczema, and Hay Fever: A General Population-based Cohort Study American Journal of Epidemiology2007 May 1;165(9):1023-30[Tata L J, Lewis S A, Mckeever T M, Smith C J P, Doyle P, Smeeth L, Gibson J E & Hubbard R B=Congenital malformation in children born to women with asthma16:S1-S274 (271)-Toh S, Garca Rodrguez LA & Hernndez-Daz S.Use of antidepressants and risk of lung cancerCancer Causes Control Aug 200718(10):1055-64(Garcia Rodriguez LA & Barreales Tolosa LsRisk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general populationGastroenterology 2007132(2): 498-506&Hernandez-Diaz S & Garcia Rodriguez LA=Non-steroidal anti-inflammatory drugs and risk of lung cancer$International Journal of Cancer 2007120, 1565 1572#Cooper S C, Graham P & Trudgill N JkRisk factors for the development of oesophageal cancer in Barrett s oesophagus: a primary care cohort study132(4) Suppl 2: A420Maguire A, Douglas I & Smeeth L_Patterns of cholesterol levels in patients treated with lipid lowering drugs in UK primary careMPoster presentation ISPE (Canada) - Pharmacoepidemiology and Drug Safety 200716:S1-S274 (481))Maguire A, Douglas, Smeeth L & Thompson MyDeterminants of cholesterol and triglyceride recording in patients treated with lipid lowering therapy in UK primary care16:S1-S274 (480),Maguire A, Schwalm M S, Douglas I & Smeeth LVClassification of hyperlipidemia from automated primary care data in the UK and France16:S1-S274 (424)RSiyambalapitiya S, Bulugahapitiya U, Sithole J, Song S, Fernando D J S and Idris ICombining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With DiabetesDiabetes Care 30:2025-2029TArellano F M, Yood M U, Wentworth C E, Oliveria S A, Rivero E, Verma A & Rothman K J)pharmacoepidemiology and drug safety 2006 15: 861 872GBlak B T, Mullins C D, Simoni-Wastila L, Shaya F T, Cooke C E, Weir M RaTrends in Angiotensin II Receptor Blocker (ARB) prescribing among general practitioners in the UKEValue In Health, Podium presentation, ISPOR, Copenhagen, Denmark 2006Vol 9 (6): A204GBlak B T, Weir M R, Simoni-Wastila L, Shaya F T, Cooke C E, Mullins C D[Antihypertensive drug budget impact of the Angiotensin II Receptor Blockers (ARB) in the UKValue In Health. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference, Copenhagen, Denmark 2006Vol 9 (6): A343%Blak BT, Dattani H, Bourke A & Page MrHas the Quality and Outcomes Framework (QOF) Scheme Impacted upon General Practitioners (GPs) Clinical Practice? UThe National Institute of Clinical Excellence (NICE) conference. Birmingham, UK 2006Poster presentationBlak B T, Thompson M, Bourke ANational Representativeness and Data Quality of the Health Improvement Network (THIN) Database of Primary Care Information for Epidemiological Researchf9th Annual Conference of the UK Federation of Primary Care Research Organisations. Liverpool, UK 2006Podium presentationDGribbin J, Hubbard R B , Le Jeune I , Smith C J P, West J & Tata L JRIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 2006 61:980-985'Gulliford M C, Charlton J & Latinovic RQRisk of Diabetes Associated With Prescribed Glucocorticoids in a Large PopulationDiabetes care 200629 (12): 2728-296Gulliford M C, Latinovic R, Charlton J, & Hughes R A CYIncreased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetesDiabetes care 200629(8): 1929-19306Haynes K, Thompson M, Dattani H, Bourke A & Hennessy SpChallenges in obtaining ethical approval for a pilot study to obtain biosamples in a UK medical records databaseBPharmacoepidemiology and drug safety (ICPE, Lisbon, Portugal) 2006<}15:(S1):S137-1382Jara M M, Lanes S F, Wentworth C, May C & Kesten S1Comparative safety of long-acting bronchodilators 15: (S1):S752Kell P, Hvidsten K, Morant S, Harnett J & Bridge SbFactors That Predict Switching Phosphodiesterase Type 5 Inhibitor Medication in the United Kingdom#The Journal of Sexual Medicine 2006fValidation studies of The Health Improvement Network (THIN) Database for pharmacoepidemiology researchDPharmacoepidemiology and drug safety. (ICPE, Lisbon, Portugal) 200615: (S1):S233-234UMortimer K, Tata L J , Smith C J P, West J, Harrison T W , Tattersfield A & Hubbard RPOral and inhaled corticosteroids and adrenal insufficiency: a case-control study 61(5): 405-85Price D, Morant S V, Horne R, Pettitt D & MacDonald THDeterminants of long acting bronchodilator adherence in UK COPD patients?Poster presented at the 16th ERS Annual Congress in Munich 2006,Reilly K, Morant S, Bloomfield G & Chapple CDiagnosis and Treatment of Lower Urinary Tract Symptoms, Overactive Bladder, and Benign Prostatic Hyperplasia in Men in UK General Practice@36th Annual Meeting of the International Continence Society 2006&Rubino A, McQuay L, Kvasz M & Tennis P}Population-Based Study of Time to Insulin After Failure of Oral Antidiabetic (OA) Therapy in Type 2 Diabetes (T2DM) in the UKEAnnual meeting of the American Diabetes Association (Washington) 2006mTime to insulin after failure of oral antidiabetic therapy in type 2 diabetes: A UK population-based analysis 15: (S1):S51<Smeeth L, Cook C, Thomas S, Hall A J, Hubbard R & Vallance P`Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting Lancet 2006 367: 1075 79HVan Staa T P, Geusens P, Kanis J A, eufkens H G M, Gehlbach S & Cooper C]A simple clinical score for estimating the long-term risk of fracture in postmenopausal womenQJM 200699(10):673-682-Alder J, Mayhew L, Moody S, Morris R & Shah RNThe chronic disease burden - An analysis of health risks and health care usage+Cass Business School (City University) 2005ISBN 1 - 901615-87-14Arellano F M , Wentworth C E, May C, Verma A & Cid JPatterns of discontinuation, Dose modification and switching among users of prescription Non-Steroidal Anti-Inflammatory Drugs (NSAID) including Cyclo-Oxygenase 2 Inhibitors (COX-2) in the UK population)Pharmacoepidemiology and Drug Safety 2005 14: S1: (003)CArellano F M, Wentworth C E, May C, Verma A, Rivero E & Rothman K JUse of prescription Cyclo-Oxygenase 2 inhibitors (COX-2) and Non COX-2 Non-Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population14: S141: (283)AArellano F M, Yood M U, Wentworth C E, Oliveria S A & Rothman K JUse of prescription Non-Steroidal Anti-Inflammatory Drugs (NSAID) Including Cyclo-Oxygenase 2 Inhibitors (COX-2) in a UK Population and a US Population14: S190: (382)THubbard R, Lewis S A, West J, Smith C, Godfrey C, Smeeth L, Farrington P & Britton JsBupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network Thorax 200560(10): 848-506Hubbard R, Lewis S, Godfrey C, Smeeth L & Farrington PaUse of nicotine replacement therapy and the risk of acute myocardial infarction, stroke and deathTobacco Control 200514(6): 416-421bFactors that predict switching Phosphodiesterase type 5 Inhibitor medication in the United KingdomS8th Congress of the European Society for Sexual Medicine - Copenhagen, Denmark 2005vTata L J, Fortune P J, Hubbard R B, Smeeth L, Hawkey C J, Smith C J P, Whitaker H J, Farrington C P, Card T R & West JDoes concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 2005 22: 175-181<Van Staa T P, Geusens P, Boonen A, Leufkens H G M & Cooper CQAn individualised model of cost-effectiveness of bisphosphonates in elderly women Bone 2005 36 (S2):S1382Van Staa T P, Geusens P, Leufkens H G M & Cooper CCPersistence to bisphosphonate treatment in actual clinical practice 36 (S2):S412?Van staa T P, Geusens P, Pols H A P, De Laet C & Leufkens H G McA simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids Q J Med 2005 98:191 198 Bourke A, Dattani H & Robinson M]Feasibility Study and Methodology to create a Quality Evaluated Database of Primary Care DataInformatics in Primary Care2004 12(3):171-7RHubbard R, Smith C, Smeeth L, Farrington P, West J, Lewis S, Godfrey C & Britton JThe Risk of Fits, Diagnosis of Epilepsy and Death after First Prescription for Bupropion: An Analysis of The Health Improvement Network (THIN) Database)Pharmacoepidemiology and Drug Safety 2004(13): S22 (S1-S334)Page M & Dattani HwFeasibility Study and Methodology to Establish a System to Improve Recording of Quality Indicators in Primary Care DataSAnnual Scientific Meeting,  Moving from policy to reality-How was it for you? 2004:Van Staa T P, Geusens P, Leufkens H, Gehlbach S & Cooper C]The estimation of the 5-year probability of fracture in a general population of elderly womenJ Bone Miner Res 2004 19 (S1);S292 Anonymous&New Medical Research Database Launched%PharmacoEconomics & Outcome News 2003(436):3No.*Gopal M, Haynes K, Bellamy S L, & Arya L AkDiscontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms3American College of Obstetricians and Gynecologists Vol: 112 (6) Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations Implications for COX-2 cardiovascular profileVol 3 Issue s3:199 A Pharmacoepidemiology and Drug Safety, 2008 ISPE, Copenhagen 2008Q (J"D4-  ? Czf!U"Y`  J#/XG]Wb)x^ l  L  %  [cc -  0~&3A6JNFSWHY  dMbP?_*+%+(&LPage &P&CJan 2009&RTHIN Publications &M&d2?'M&d2?(M&d2?)M&d2?M\\EPC-NT01\EPC-PR02? dXXLetter.HP LaserJet 4000 Series PCL 62xeKOAjhD]@EH3v&L Ԉ!fbׂ2LܱQ3K\Ɲ_+._~TĻnS7'M/i`Ը{'goU ci#f]p | =}[9o<= Ons4{svL-tvԢSڹ.?ξz>ON!8a“o2~7OAV tvU!al{7 !? "@~ "`@~ '@U@ !L !M !N "O~ "`@~ 'U@ !T !Q !U "V~ "`@~ 'T@ !P !Q !R "S~ "`@~ 'T@ !D !E !F "G~ #`@B\ XTTTTTTTTTTTTTTTTTTTTTTTTTTTTT !"#$%&'()*+,-./0123456789:;<=>?~ '@T@ $ % $l #~ "`@~ !'T@ !$ !% !$l !#~ !"`@~ "'S@ "$ "% "$l "#~ ""`@~ #'S@ #$ #% #$l ##~ #"`@~ $'@S@ $$ $% $$l $#~ $"`@~ %'S@ %$ %% %$l %#~ %"`@~ &'R@ &$ &% &$ &#~ &"`@~ ''R@ '$ '% '$l '#~ '"`@~ ('@R@ ($ (% ($l (#~ ("`@~ )'R@ )$ )% )$l )#~ )"`@~ *'Q@ *$ *% *$l *#~ *"`@~ +'Q@ +$ +% +$ +#~ +"`@~ ,'@Q@ ,$ ,% ,$l ,#~ ,"`@~ -'Q@ -$| -%} -$~ -#]~ -"`@~ .'P@ .$y .%z .$l .#{~ ."`@~ /'P@ /$v /%w /$l /#x~ /"`@~ 0'@P@ 0$t 0%1 0$u 0#]~ 0"`@~ 1'P@ 1$q 1%r 1$l 1#s~ 1"`@~ 2'O@ 2$n 2%o 2$l 2#p~ 2"`@~ 3'O@ 3$j 3%k 3$l 3#m~ 3"`@~ 4'N@ 4! 4! 4! 4"~ 4#\@~ 5'N@ 5! 5! 5! 5"~ 5#\@~ 6'M@ 6! 6! 6! 6"~ 6#\@~ 7'M@ 7! 7! 7! 7"~ 7#\@~ 8'L@ 8! 8! 8! 8"~ 8"\@~ 9'L@ 9! 9! 9! 9"~ 9#\@~ :'K@ :! :! :! :"~ :#\@~ ;'K@ ;! ;! ;! ;"~ ;#\@~ <'J@ <! <! <! <"~ <#\@~ ='J@ =! =! =! ="~ =#\@~ >'I@ >! >! >! >"~ >#\@~ ?'I@ ?! ?! ?! ?"~ ?#\@D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_~ @'H@ @! @! @! @"~ @#\@~ A'H@ A! A! A! A"~ A#\@~ B'G@ B! B! B! B"~ B#\@~ C'G@ C! C! C! C"~ C#\@~ D'F@ D! D! D! D"~ D#\@~ E'F@ E! E! E! E"~ E"\@~ F'E@ F! F! F! F"~ F"\@~ G'E@ G! G! G! G"~ G#\@~ H'D@ H! H! H! H"~ H#\@~ I'D@ I! I! I! I"~ I"\@~ J'C@ J! J! J! J"~ J#\@~ K'C@ K! K! K! K"~ K#\@~ L'B@ L! L! L! L"~ L#\@~ M'B@ M! M! M! M"~ M#\@~ N'A@ N!F N!G N!H N"I~ N"X@~ O'A@ O!B O!C O!D O"E~ O"X@~ P'@@ P!= P!@ P!2 P"A~ P"X@~ Q'@@ Q!= Q!> Q!? Q"~ Q"X@~ R'?@ R!: R!; R!<R"~ R"X@~ S'>@ S!7 S!8 S!9S"~ S"X@~ T'=@ T!4 T!5 T! T"6~ T"X@~ U'<@ U! U!1 U!2 U"3~ U"X@~ V';@ V!. V!/ V!0 V"~ V"X@~ W':@ W!+ W!, W!) W"-~ W"X@~ X'9@ X!' X!( X!) X"*~ X"X@~ Y'8@ Y!# Y!$ Y!% Y"&~ Y"X@~ Z'7@ Z! Z!  Z!! Z""~ Z"X@~ ['6@ [! [! [! ["~ ["X@~ \'5@ \! \! \! \"~ \"X@~ ]'4@ ]! ]! ]! ]"~ ]"X@~ ^'3@ ^! ^! ^! ^"~ ^"X@~ _'2@ _!  _!  _!  _"~ _"X@D lTTTTTTTTTTTTTTTTTTPPTTTTTTTTTTT`abcdefghijklmnopqrstuvwxyz{|}~~ `'1@ `! `! `!  `" ~ `"X@~ a'0@ a!m a!n a!o a"p~ a"T@~ b'.@ b!j b!k b!h b"l~ b"T@~ c',@ c!f c!g c!h c"i~ c"T@~ d'*@ d!b d!c d!d d"e~ d"T@~ e'(@ e!. e!` e!ae"~ e"T@~ f'&@ f!\ f!] f!^ f"_~ f"T@~ g'$@ g!X g!Y g!Z g"[~ g"T@~ h'"@ h!U h!V h!P h"W~ h"T@~ i' @ i!R i!S i!P i"T~ i"T@~ j'@ j!N j!O j!P j"Q~ j"T@~ k'@ k!J k!K k!L k"M~ k"T@~ l'@ l!| l!} l!~ l"~ l"P@~ m'@ m!y m!z m!{ m"~ m"P@~ n'@ n!u n!v n!w n"x~ n"P@~ o'@ o!q o!r o!s o"t~ o"P@~ p'? p! p! p! p"~ p"L@ qr( s t u v w x y z { | } ~ DlTTTTTPTTTTTTTTTTT                                D@l                                D@l                                D@l         2 (  Z  # $ztyK yK Hhttp://www.epic-uk.org/yX;H,]ą'c"0@@@`` ( ( (? (K]`$z4.< " <#THIN PUBLICATIONS www.epic-uk.org < I!0I"^V  C A?tCSD_epic_logoyK yK Hhttp://www.epic-uk.org/yX;H,]ą'c#" @@aV]&`.<>@ 7ggLh?hpTHIN Publications -  dc  dMbP?_*+%&M&d2?'M&d2?(M&d2?)M&d2?M\\EPC-NT01\EPC-PR02? dXXLetter.HP LaserJet 4000 Series PCL 62xeKOAjh\` ViY@b&F7$gZ&ݐ`Y7_aɎN_=81.[MIe Ƶ&v_D9ƌF̺ytmAnآ<%sp MVܛkP.Ҏzv2E_gi_B߀o!8a“?E~dOS8./-z,U!h=ۏpz:නS9GC9s8Wɸk{!AmNvO~ߵ/_Nՠ\%7ە`~9%w9Y*N[L_/7ZDQTfy2 a6! 뇜;Eco9m!ι < wQg<" dXXc-U  (      `A?#" @@< ]& `3<>@7bb gg Oh+'0HP\x Mustafa DungarwallaMicrosoft Excel@r)w@(@)w՜.+,D՜.+,4 PXd lt| ' THIN PublicationPLEASE READ - Sorting Options  Worksheets 8@ _PID_HLINKSA jihttp://www.epic-uk.org/jihttp://www.epic-uk.org/  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./012456789:<=>?@ABRoot Entry FWorkbookeSummaryInformation(3DocumentSummaryInformation8;